• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马萨诸塞州处方医生对非主动要求的处方药监测项目报告的回应。

Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.

作者信息

Thomas Cindy Parks, Kim Meelee, Nikitin Ruslan V, Kreiner Peter, Clark Thomas W, Carrow Grant M

机构信息

Schneider Institutes for Health Policy, Brandeis University, Waltham, MA, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):950-7. doi: 10.1002/pds.3666. Epub 2014 Jun 12.

DOI:10.1002/pds.3666
PMID:24920376
Abstract

PURPOSE

To describe prescriber response to unsolicited patient reports from the Massachusetts prescription drug monitoring program (PDMP).

METHODS

Prescribers were surveyed upon receipt of unsolicited reports of their patients' prescription history and three months later. We assessed prescribers' awareness of other prescribers listed in the report, their clinical assessment of medical necessity of all prescribed medications, actions taken by prescribers after receiving the report, and usefulness of the report.

RESULTS

Of the 333 respondents to the initial survey, only 28 (8.4%) were aware of most, all, or nearly all other prescribers. A total of 146 (43.8%) reported having sufficient knowledge to determine whether the prescriptions were medically necessary, of whom 102 (69.6%) felt the prescriptions were unwarranted. Of the 163 respondents to the follow-up survey, 31.3% added the report to the patient's file, 22.7% discussed the report with other prescribers on the report, 21.5% took no action, and 6% discussed the report with the patient (representing two-thirds of respondents who saw the patient after receiving the report). Most respondents felt that the report was useful for their practice and easy to understand.

CONCLUSIONS

Unsolicited reporting of PDMP data has the potential to improve clinical practice by alerting providers about patients with multiple prescribers and potentially medically unnecessary prescriptions.

摘要

目的

描述开处方者对来自马萨诸塞州处方药监测项目(PDMP)的非主动提供的患者报告的反应。

方法

在收到关于其患者处方历史的非主动报告时及三个月后对开处方者进行调查。我们评估了开处方者对报告中列出的其他开处方者的知晓情况、他们对所有已开处方药物医疗必要性的临床评估、开处方者在收到报告后采取的行动以及报告的有用性。

结果

在初始调查的333名受访者中,只有28人(8.4%)知晓大多数、所有或几乎所有其他开处方者。共有146人(43.8%)报告有足够的知识来确定这些处方是否有医疗必要性,其中102人(69.6%)认为这些处方是不必要的。在后续调查的163名受访者中,31.3%将报告添加到患者档案中,22.7%与报告中的其他开处方者讨论了该报告,21.5%未采取行动,6%与患者讨论了该报告(占收到报告后见到患者的受访者的三分之二)。大多数受访者认为该报告对他们的工作有用且易于理解。

结论

非主动报告PDMP数据有可能通过提醒提供者注意有多个开处方者且可能存在医疗上不必要处方的患者来改善临床实践。

相似文献

1
Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.马萨诸塞州处方医生对非主动要求的处方药监测项目报告的回应。
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):950-7. doi: 10.1002/pds.3666. Epub 2014 Jun 12.
2
Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.州级处方药物监测项目对阿片类镇痛药处方医生的非邀约报告:一项基于匹配对照群组的观察性研究。
Pain Med. 2018 Jul 1;19(7):1396-1407. doi: 10.1093/pm/pnx044.
3
Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.政策与实践:医疗和教育环境中处方治疗与耐用医疗设备的比较
Pediatrics. 2004 Nov;114(5):e612-25. doi: 10.1542/peds.2004-1063.
4
Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter?开处方者和药剂师对处方监测计划(PMP)数据的请求:PMP的结构重要吗?
J Pain Palliat Care Pharmacother. 2013 Jun;27(2):136-42. doi: 10.3109/15360288.2013.788598. Epub 2013 May 20.
5
An Experimental Test of the Effectiveness of Unsolicited Reporting by a Prescription Drug Monitoring Program in Reducing Inappropriate Acquisition of Opioids.未经请求的报告对减少阿片类药物不当获取的有效性的实验测试:处方药物监测计划。
Pain Med. 2019 May 1;20(5):944-954. doi: 10.1093/pm/pny095.
6
Impact of prescription drug-monitoring program on controlled substance prescribing in the ED.处方药监测计划对急诊科管制药品处方的影响。
Am J Emerg Med. 2015 Jun;33(6):781-5. doi: 10.1016/j.ajem.2015.03.036. Epub 2015 Mar 18.
7
Evaluation of Florida physicians' knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool.评估佛罗里达州医生对于将该州处方药监测计划作为一种处方工具的了解程度和态度。
Pain Med. 2014 Dec;15(12):2013-9. doi: 10.1111/pme.12476. Epub 2014 Jun 14.
8
Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.佛罗里达州的处方药监测计划和“药丸工厂”法对阿片类药物处方和使用的影响。
JAMA Intern Med. 2015 Oct;175(10):1642-9. doi: 10.1001/jamainternmed.2015.3931.
9
Characteristics of state prescription drug monitoring programs: a state-by-state survey.州处方药监测项目的特点:一项逐州调查
Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):847-51. doi: 10.1002/pds.4003. Epub 2016 Apr 8.
10
Provider Reactions to Opioid-Prescribing Report Cards.提供者对阿片类药物处方报告卡的反应。
J Public Health Manag Pract. 2022;28(2):E518-E524. doi: 10.1097/PHH.0000000000001382.

引用本文的文献

1
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paper.CTN-0138:基于社区药店的处方药物监测计划阿片类药物风险评估工具的改编、实施和整群随机试验 - 方案论文。
Addict Sci Clin Pract. 2024 Nov 18;19(1):82. doi: 10.1186/s13722-024-00514-1.
2
Changes in opioid prescribing and prescription drug monitoring program utilization following electronic health record integration-Massachusetts, 2018.电子病历整合后阿片类药物处方和处方药物监测计划使用的变化-马萨诸塞州,2018 年。
Pain Med. 2024 May 3;25(6):380-386. doi: 10.1093/pm/pnae012.
3
Efficacy of interventions targeted at physician prescribers of opioids for chronic non-cancer pain: an overview of systematic reviews.
针对慢性非癌痛的阿片类药物处方医师的干预措施的疗效:系统评价概述。
BMC Med. 2024 Feb 20;22(1):76. doi: 10.1186/s12916-024-03287-1.
4
Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers.通过马里兰州处方药监测计划(PDMP)进行的主动报告通知(URNs):提供者的特征
Drug Alcohol Depend Rep. 2022 Oct 29;5:100111. doi: 10.1016/j.dadr.2022.100111. eCollection 2022 Dec.
5
Using Economic Evaluation to Inform Responses to the Opioid Epidemic in the United States: Challenges and Suggestions for Future Research.利用经济评估为美国阿片类药物流行的应对措施提供信息:对未来研究的挑战和建议。
Subst Use Misuse. 2022;57(5):815-821. doi: 10.1080/10826084.2022.2026969. Epub 2022 Feb 14.
6
Brief intervention medication therapy management: Establishment of an opioid misuse intervention model delivered in a community pharmacy.简短干预药物治疗管理:在社区药房中实施的阿片类药物滥用干预模式的建立。
Am J Health Syst Pharm. 2021 Feb 8;78(4):310-319. doi: 10.1093/ajhp/zxaa389.
7
Perception of prescription drug monitoring programs as a prevention tool in primary medical care.将处方药监测项目视为初级医疗保健中的一种预防工具。
Res Social Adm Pharm. 2020 Sep;16(9):1306-1308. doi: 10.1016/j.sapharm.2019.03.012. Epub 2019 Mar 26.
8
Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention.医生报告称,在接受了学术强化干预后,他们采用了更安全的阿片类药物处方行为。
Subst Abus. 2018;39(2):218-224. doi: 10.1080/08897077.2018.1449175. Epub 2018 May 4.
9
Targeting practitioners: A review of guidelines, training, and policy in pain management.针对从业者:疼痛管理指南、培训及政策综述
Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1(Suppl 1):S22-S30. doi: 10.1016/j.drugalcdep.2016.08.641.
10
Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.临床医生在临床实践和决策中对处方药监测项目的使用。
Pain Med. 2017 Jun 1;18(6):1063-1069. doi: 10.1093/pm/pnw251.